Redefining Available Therapy in Oncology Accelerated Approval Decisions.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39454117.
- Also identified by DOI 10.1200/JCO.24.00892.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
When weighing rapid approval for follow-on drugs, should @FDAOncology recognize the drugs that came before?
Medical subject headings
- Drug Approval
- Neoplasms
- Medical Oncology
- Antineoplastic Agents